Buzzard Pharmaceuticals AB

ABActive

Org 5590736855Skeppsbron 16, 111 30 StockholmResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2016 · 9 years old1-4 employees

Overview Financials People & ownership Related companies

Buzzard Pharmaceuticals AB is a Swedish AB based in Stockholm, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2016, the company reported revenue of SEK 0 in its latest annual filing.

Revenue 2025

SEK 0

EBITDA margin

—

Net profit 2025

SEK -3,8M

-479% vs 2024

Key ratios

See full ratios →

98.6%

This company

20212025

2.3×

This company

20212025

-2.8%

This company

20212025

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK 0	—
EBITDA	SEK -2,7M	-942%
Net profit	SEK -3,8M	-479%
Total assets	SEK 138M	+5%
Equity	SEK 136,1M	+5%
Employees	—	—

Contact

Address

Skeppsbron 16, 111 30 Stockholm

dechateau@buzzardpharma.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Buzzard Pharmaceuticals AB?

Buzzard Pharmaceuticals AB is registered with Bolagsverket / SCB under Org 5590736855.

Who is the CEO of Buzzard Pharmaceuticals AB?

Maarten De Chateau is the CEO of Buzzard Pharmaceuticals AB, in role since 2020.

Who is the chairman of Buzzard Pharmaceuticals AB?

Lars Urban Paulsson chairs the board of Buzzard Pharmaceuticals AB, in role since 2020.

Where is Buzzard Pharmaceuticals AB headquartered?

Buzzard Pharmaceuticals AB's registered address is Skeppsbron 16.

Buzzard Pharmaceuticals AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Buzzard Pharmaceuticals AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Buzzard Pharmaceuticals AB